A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Background The primary systemic vasculitides usually associated with autoantibodies to neutrophil cytoplasmic antigens include Wegener's granulomatosis and microscopic polyangiitis. We investigated whether exposure to cyclophosphamide in patients with generalized vasculitis could be reduced by substitution of azathioprine at remission. Methods We studied patients with a new diagnosis of generalized vasculitis and a serum creatinine concentration of 5.7 mg per deciliter (500 micromol per liter) or less. All patients received at least three months of therapy with oral cyclophosphamide and prednisolone. After remission, patients were randomly assigned to continued cyclophosphamide therapy (1.5 mg per kilogram of body weight per day) or a substitute regimen of azathioprine (2 mg per kilogram per day). Both groups continued to receive prednisolone and were followed for 18 months from study entry. Relapse was the primary end point. Results Of 155 patients studied, 144 (93 percent) entered remission and were randomly assigned to azathioprine (71 patients) or continued cyclophosphamide (73 patients). There were eight deaths (5 percent), seven of them during the first three months. Eleven relapses occurred in the azathioprine group (15.5 percent), and 10 occurred in the cyclophosphamide group (13.7 percent, P=0.65). Severe adverse events occurred in 15 patients during the induction phase (10 percent), in 8 patients in the azathioprine group during the remission phase (11 percent), and…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment includes prednisone, cyclophosphamide, or methotrexate.237,238,245”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [245]
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Self-citationWegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
FAUCI, A. S., HAYNES, B. F., KATZ, P., & WOLFF, S. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-76 · Cited by 2,001
Short form 36 (SF36) health survey questionnaire: normative data for adults of working age.
Jenkinson, C., Coulter, A., & Wright, L. (1993) · BMJ · doi:10.1136/bmj.306.6890.1437 · Cited by 1,718
Falk, R. J., Terrell, R. S., Charles, L. A., & Jennette, J. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4115 · Cited by 1,261
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056
Self-citationSavige, J., Gillis, D., Benson, E., Davies, D., Esnault, V., Falk, R. J., Chris Hagen, E., Jayne, D., Charles Jennette, J., Paspaliaris, B., et al. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.4.507 · Cited by 884
Self-citationValidation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
Hagen, E. C., Daha, M. R., Hermans, J., Andrassy, K., Csernok, E., Gaskin, G., Lesavre, P., Lüdemann, J., Rasmussen, N., Sinico, R. A., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00807.x · Cited by 740
Self-citationStegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729 · cited 1×
“≥1 Event 52 (34) 15 (10) 29 (41) 8 (11) 32 (44) 7 (10) 84 (54)”
Self-citationExley, A. R., Bacon, P. A., Luqmani, R. A., Kitas, G. D., Gordon, C., Savage, C. O. S., & Adu, D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400222 · Cited by 619
Self-citationCyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis
Fauci, A. S., Katz, P., Haynes, B. F., & Wolff, S. M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908023010503 · Cited by 526
Guillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401213 · Cited by 509
COHENTERVAERT, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92205-v · Cited by 411
Falk, R. J., Hogan, S., Carey, T. S., Jennette, J. C., & The Glomerular Disease Collaborative Network (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-9-656 · Cited by 391
Hogan, S. L., Nachman, P. H., Wilkman, A. S., Jennette, J. C., & Falk, R. J. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7123 · Cited by 386
Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
Pusey, C. D., Rees, A. J., Evans, D. J., Peters, D. K., & Lockwood, C. M. (1991) · Kidney International · doi:10.1038/ki.1991.272 · Cited by 358 · cited 1×
“(%) Wegener’s granulomatosis Microscopic polyangiitis 46 (61) 30 (39) 49 (62) 30 (38) 95 (61) 60 (39)”
Self-citationThe value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical review
Groot, K. D., Adu, D., & Savage, C. O. S. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.10.2018 · Cited by 335 · cited 1×
“(%) Wegener’s granulomatosis Microscopic polyangiitis 46 (61) 30 (39) 49 (62) 30 (38) 95 (61) 60 (39)”
Westman, K. W., Bygren, P. G., Olsson, H., Ranstam, J., & Wieslander, J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95842 · Cited by 318
Self-citationHauer, H. A., Bajema, I. M., Van Houwelingen, H. C., Ferrario, F., Noël, L.-H., Waldherr, R., Jayne, D. R. W., Rasmussen, N., Bruijn, J. A., & Hagen, E. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00089.x · Cited by 317
Self-citationAnti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/ge9e-mq51 · Cited by 297
NOWACK, R., GÖBEL, U., KLOOKER, P., HERGESELL, O., ANDRASSY, K., & VAN DER WOUDE, F. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1091965 · Cited by 247
Adu, D. (1997) · QJM · doi:10.1093/qjmed/90.6.401 · Cited by 228
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis
Bajema, I. M., Hagen, E. C., Hermans, J., Noël, L.-H., Waldherr, R., Ferrario, F., van der Woude, F. J., Bruijn, J. A., & for the EC/BCR Project for ANCA-Assay Standardisation (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00758.x · Cited by 212
Self-citationA Controlled Trial of Combined Therapy for Newly Diagnosed Severe Childhood IgA Nephropathy
YOSHIKAWA, N., ITO, H., SAKAI, T., TAKEKOSHI, Y., HONDA, M., AWAZU, M., ITO, K., IITAKA, K., KOITABASHI, Y., YAMAOKA, K., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101101 · Cited by 203
ANCA and predicting relapse in systemic vasculitis
(1995) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a069033 · Cited by 199
Self-citationde Groot, K., Reinhold‐Keller, E., Tatsis, E., Paulsen, J., Heller, M., Nölle, B., & Gross, W. L. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391215 · Cited by 185
Self-citationActivity loss and the onset of depressive symptoms: Do some activities matter more than others?
Katz, P. P., & Yelin, E. H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1194::aid-anr203>3.0.co;2-6 · Cited by 175
Jayne, D. R., & Rasmussen, N. (1997) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63594-5 · Cited by 169
Self-citationReinhold‐Keller, E., Kekow, J., Schnabel, A., Schmitt, W. H., Heller, M., Beigel, A., Duncker, G., & Gross, W. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370622 · Cited by 166
Self-citationDe’Oliviera, J., Gaskin, G., Dash, A., Rees, A. J., & Pusey, C. D. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90098-5 · Cited by 130
Self-citationBrooks, C. J., King, W. J., Radford, D. J., Adu, D., McGrath, M., & Savage, C. O. S. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-835.x · Cited by 121 · cited 1×
“≥1 Event 52 (34) 15 (10) 29 (41) 8 (11) 32 (44) 7 (10) 84 (54)”
10 Disease assessment and management of the vasculitides
Luqmani, R. A., Exley, A. R., Kitas, G. D., & Bacon, P. A. (1997) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(97)80052-0 · Cited by 117
Self-citationRasmussen, N., Jayne, D. R. W., Abramowicz, D., Andrássy, K., BACON, P. A., Tervaert, J.-W. C., Dadonlené, J., Feighery, C., van Es, L. A., Ferrario, F., et al. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06161.x · Cited by 111
Self-citationExley, A., BACON, P. A., Luqmani, R. A., Kitas, G. D., Carruthers, D. M., & Moots, R. J. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.1.57 · Cited by 106
Self-citationSuominen, P., Möttönen, T. T., Rajamäki, A., & Irjala, K. M. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1016::aid-anr9>3.0.co;2-3 · Cited by 100
Self-citationEvidence‐based treatment of systemic vasculitis
Jayne, D. R. W. (2000) · Rheumatology · doi:10.1093/rheumatology/39.6.585 · Cited by 96
Self-citationKING, W. J., Brooks, C. J., Holder, R. L., Hughes, P., Adu, D., & Savage, C. O. S. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00615.x · Cited by 77
Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis
Haubitz, M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.8.2074 · Cited by 66
VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
BACON, P. A., Moots, R. J., Exley, A., Luqmani, R. A., & Rasmussen, N. (1995) · PubMed · Cited by 49
Self-citationMethods to detect autoantibodies to neutrophilic granulocytes
Wiik, A. S., Rasmussen, N., & Wieslander, J. (1993) · Springer eBooks · doi:10.1007/978-94-011-5444-4_9 · Cited by 32
Self-citationJayne, D. R. W., & Rasmussen, N. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.8.737 · Cited by 29
Self-citationPathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Research works printed but not linked: 10
- Jennette JC, 1989, Am J Pathol, 135, 921
- Hauer HA, 1998, Clin Exp Immunol, 112, 28
- 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A · doi:10.1002/(sici)1096-9896(200002)190:3<349::aid-path524>3.0.co;2-a
- 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J · DOI · Paper page
- Jayne DR, 1995, QJM, 88, 127
- Luqmani RA, 1994, QJM, 87, 671
- Bacon PA, 1995, Clin Exp Rheumatol, 13, 275
- 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q · doi:10.1002/1529-0131(199810)41:10<1835::aid-art16>3.0.co;2-q
- Szpirt WM, 1996, Int J Artif Organs, 19, 501
- 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F · DOI · Paper page
Cited by
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationRituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Self-citationWatts, R., Lane, S., Hanslik, T., Hauser, T., Hellmich, B., Koldingsnes, W., Mahr, A., Segelmark, M., Cohen-Tervaert, J. W., & Scott, D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054593 · Cited by 1,359
Self-citationModification and validation of the Birmingham Vasculitis Activity Score (version 3)
Mukhtyar, C., Lee, R., Brown, D., Carruthers, D., Dasgupta, B., Dubey, S., Flossmann, O., Hall, C., Hollywood, J., Jayne, D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101279 · Cited by 1,224
Self-citation
Metadata
- Authors
- Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., Gross, W., Hagen, E. C., Mirapeix, E., Pettersson, E., Siegert, C., Sinico, A., Tesar, V., Westman, K., & Pusey, C.
- Affiliations
- Addenbrooke's Hospital (GB)
- Rigshospitalet (DK)
- University of Birmingham (GB)
- Maastricht University (NL)
- University of Helsinki (FI)
- Imperial College London (GB)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Lübeck (DE)
- Hospital Clínic de Barcelona (ES)
- Leiden University Medical Center (NL)
- Azienda Ospedaliera Ospedale San Carlo Borromeo (IT)
- Lund University (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-03
- Volume
- 349
- Issue
- 1
- Pages
- 36-44
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1981535363
- Cited by
- 1,348
- References
- 44
- Citations by year
- 2026: 6 · 2025: 22 · 2024: 24 · 2023: 37 · 2022: 48 · 2021: 36 · 2020: 51 · 2019: 46 · 2018: 51 · 2017: 46 · 2016: 51 · 2015: 80 · 2014: 77 · 2013: 80 · 2012: 83
- FWCI
- 48.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- ANCA-associated vasculitis, maintenance therapy, cyclophosphamide, azathioprine, granulomatosis with polyangiitis, microscopic polyangiitis, relapse, remission, prednisolone, adverse events
- MeSH terms
- Adult, Aged, Azathioprine, Cyclophosphamide, Drug Therapy, Combination, Female, Glucocorticoids, Humans, Immunosuppressive Agents, Male, Middle Aged, Neutropenia, Prednisolone, Recurrence, Remission Induction, Vasculitis, Antibodies, Antineutrophil Cytoplasmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.